Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How to Image Cardiac Amyloidosis: A Practical Approach.

Literature DB >> 31607664

How to Image Cardiac Amyloidosis: A Practical Approach.

Sharmila Dorbala¹, Sarah Cuddy², Rodney H Falk³.

Abstract

Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with a median survival from diagnosis, if untreated, ranging from <6 months for light chain amyloidosis to 3 to 5 years for transthyretin amyloidosis. Early diagnosis and accurate typing of CA are necessary for optimal management of these patients. Emerging novel disease modifying therapies increase the urgency to diagnose CA at an early stage and identify patients who may benefit from these life-saving therapies. The goal of this review is to provide a practical approach to echocardiography, cardiac magnetic resonance, and radionuclide imaging in patients with known or suspected CA.

Entities: Chemical Disease Gene Mutation Species

Keywords: CMR; PET; Tc-99m−PYP; amyloid tracers; cardiac amyloidosis; cardiac magnetic resonance; echocardiography; imaging; multimodality; pyrophosphate; radionuclide imaging

Mesh：

Year: 2019 PMID： 31607664 PMCID： PMC7148180 DOI： 10.1016/j.jcmg.2019.07.015

Source DB: PubMed Journal: JACC Cardiovasc Imaging ISSN： 1876-7591

75 in total

1. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.

Authors: Sharmila Dorbala; Divya Vangala; John Bruyere; Christina Quarta; Jenna Kruger; Robert Padera; Courtney Foster; Michael Hanley; Marcelo F Di Carli; Rodney Falk
Journal: JACC Heart Fail Date: 2014-07-09 Impact factor: 12.035

2. Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

Authors: Edward A El-Am; Angela Dispenzieri; Rowlens M Melduni; Naser M Ammash; Roger D White; David O Hodge; Peter A Noseworthy; Grace Lin; Sorin V Pislaru; Alexander C Egbe; Martha Grogan; Vuyisile T Nkomo
Journal: J Am Coll Cardiol Date: 2019-02-12 Impact factor: 24.094

3. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Authors: David Adams; Alejandra Gonzalez-Duarte; William D O'Riordan; Chih-Chao Yang; Mitsuharu Ueda; Arnt V Kristen; Ivailo Tournev; Hartmut H Schmidt; Teresa Coelho; John L Berk; Kon-Ping Lin; Giuseppe Vita; Shahram Attarian; Violaine Planté-Bordeneuve; Michelle M Mezei; Josep M Campistol; Juan Buades; Thomas H Brannagan; Byoung J Kim; Jeeyoung Oh; Yesim Parman; Yoshiki Sekijima; Philip N Hawkins; Scott D Solomon; Michael Polydefkis; Peter J Dyck; Pritesh J Gandhi; Sunita Goyal; Jihong Chen; Andrew L Strahs; Saraswathy V Nochur; Marianne T Sweetser; Pushkal P Garg; Akshay K Vaishnaw; Jared A Gollob; Ole B Suhr
Journal: N Engl J Med Date: 2018-07-05 Impact factor: 91.245

4. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Authors: Enrica Perugini; Pier Luigi Guidalotti; Fabrizio Salvi; Robin M T Cooke; Cinzia Pettinato; Letizia Riva; Ornella Leone; Mohsen Farsad; Paolo Ciliberti; Letizia Bacchi-Reggiani; Francesco Fallani; Angelo Branzi; Claudio Rapezzi
Journal: J Am Coll Cardiol Date: 2005-09-20 Impact factor: 24.094

5. Myocardial texture characterization by two-dimensional echocardiography.

Authors: A K Bhandari; N C Nanda
Journal: Am J Cardiol Date: 1983-03-01 Impact factor: 2.778

6. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.

Authors: A L Klein; L K Hatle; D J Burstow; J B Seward; R A Kyle; K R Bailey; T F Luscher; M A Gertz; A J Tajik
Journal: J Am Coll Cardiol Date: 1989-04 Impact factor: 24.094

7. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.

Authors: Andreia Biolo; Sujata Ramamurthy; Lawreen H Connors; Carl J O'Hara; Hans K Meier-Ewert; Pamela T Soo Hoo; Douglas B Sawyer; David C Seldin; David S Seldin; Flora Sam
Journal: Circ Heart Fail Date: 2008-10-14 Impact factor: 8.790

8. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.

Authors: P N Hawkins; J P Lavender; M B Pepys
Journal: N Engl J Med Date: 1990-08-23 Impact factor: 91.245

9. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis.

Authors: Francesco Salinaro; Hans K Meier-Ewert; Edward J Miller; Shivda Pandey; Vaishali Sanchorawala; John L Berk; David C Seldin; Frederick L Ruberg
Journal: Eur Heart J Cardiovasc Imaging Date: 2017-09-01 Impact factor: 6.875

10. Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.

Authors: Sanjay M Banypersad; Daniel M Sado; Andrew S Flett; Simon D J Gibbs; Jennifer H Pinney; Viviana Maestrini; Andrew T Cox; Marianna Fontana; Carol J Whelan; Ashutosh D Wechalekar; Philip N Hawkins; James C Moon
Journal: Circ Cardiovasc Imaging Date: 2012-11-28 Impact factor: 7.792

30 in total

Review 1. The roles of global longitudinal strain imaging in contemporary clinical cardiology.

Authors: Toshimitsu Kato; Tomonari Harada; Kazuki Kagami; Masaru Obokata
Journal: J Med Ultrason (2001) Date: 2022-01-28 Impact factor: 1.314

2. Amyloid Cardiopathy and Aortic Stenosis.

Authors: Leonida Gherasim
Journal: Maedica (Bucur) Date: 2021-09

3. Native T1 mapping for the diagnosis of cardiac amyloidosis in patients with left ventricular hypertrophy.

Authors: Daniel Lavall; Nicola H Vosshage; Romy Geßner; Stephan Stöbe; Sebastian Ebel; Timm Denecke; Andreas Hagendorff; Ulrich Laufs
Journal: Clin Res Cardiol Date: 2022-03-31 Impact factor: 5.460

4. Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.

Authors: Brett W Sperry; Timothy M Bateman; Esma A Akin; Paco E Bravo; Wengen Chen; Vasken Dilsizian; Fabien Hyafil; Yiu Ming Khor; Robert J H Miller; Riemer H J A Slart; Piotr Slomka; Hein Verberne; Edward J Miller; Chi Liu
Journal: J Nucl Cardiol Date: 2022-07-21 Impact factor: 3.872

5. Emerging Topics Update of the Brazilian Heart Failure Guideline - 2021.

Authors: Fabiana G Marcondes-Braga; Lídia Ana Zytynski Moura; Victor Sarli Issa; Jefferson Luis Vieira; Luis Eduardo Rohde; Marcus Vinícius Simões; Miguel Morita Fernandes-Silva; Salvador Rassi; Silvia Marinho Martins Alves; Denilson Campos de Albuquerque; Dirceu Rodrigues de Almeida; Edimar Alcides Bocchi; Felix José Alvarez Ramires; Fernando Bacal; João Manoel Rossi Neto; Luiz Claudio Danzmann; Marcelo Westerlund Montera; Mucio Tavares de Oliveira Junior; Nadine Clausell; Odilson Marcos Silvestre; Reinaldo Bulgarelli Bestetti; Sabrina Bernadez-Pereira; Aguinaldo F Freitas; Andréia Biolo; Antonio Carlos Pereira Barretto; Antônio José Lagoeiro Jorge; Bruno Biselli; Carlos Eduardo Lucena Montenegro; Edval Gomes Dos Santos Júnior; Estêvão Lanna Figueiredo; Fábio Fernandes; Fabio Serra Silveira; Fernando Antibas Atik; Flávio de Souza Brito; Germano Emílio Conceição Souza; Gustavo Calado de Aguiar Ribeiro; Humberto Villacorta; João David de Souza Neto; Livia Adams Goldraich; Luís Beck-da-Silva; Manoel Fernandes Canesin; Marcelo Imbroinise Bittencourt; Marcely Gimenes Bonatto; Maria da Consolação Vieira Moreira; Mônica Samuel Avila; Otavio Rizzi Coelho Filho; Pedro Vellosa Schwartzmann; Ricardo Mourilhe-Rocha; Sandrigo Mangini; Silvia Moreira Ayub Ferreira; José Albuquerque de Figueiredo Neto; Evandro Tinoco Mesquita
Journal: Arq Bras Cardiol Date: 2021-06 Impact factor: 2.000

6. Apolipoprotein 1 amyloidosis cardiomyopathy and the grey zone of non-invasive diagnostic algorithms: Red flags to reach the diagnosis.

Authors: Louise Plard; Amandine Pallardy; Jean-Noël Trochu; Nicolas Piriou
Journal: J Nucl Cardiol Date: 2021-02-24 Impact factor: 5.952